Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bard

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Biochemical and Biophysical Research Communications|November 9, 1970
Transient-state intermediates involved in the hydride transfer step of the glutamate dehydrogenase reactionH F Fisher, J R Bard, R A Prough
Annals of the New York Academy of Sciences|May 31, 1993
BisMSH-DTPA. A potential imaging agent for malignant melanomaD R Bard, E P Wraight, C G Knight
The American Surgeon|October 23, 2019
Traumatic PneumatoceleJacob D Edwards, Carlos J Anciano, Michael R Bard
Current Surgery|December 14, 2004
Laparoscopy in traumaClaudia E Goettler, Michael R Bard, Eric A Toschlog
New York State Journal of Medicine|September 1, 1976
Takayasu's arteritis. A worldwide entityA Lande, R Bard, P Rossi, et al.
Clinical and Experimental Rheumatology|July 1, 1985
Effect of the intra-articular injection of lutetium-177 in chelator liposomes on the progress of an experimental arthritis in rabbitsD R Bard, C G Knight, D P Page-Thomas
Biochemical Society Transactions|October 1, 1990
Targeting of a chelating derivative of a short-chain analogue of alpha-melanocyte stimulating hormone to Cloudman S91 melanomasD R Bard, C G Knight, D P Page-Thomas
British Journal of Cancer|December 1, 1990
A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanomaD R Bard, C G Knight, D P Page-Thomas
Clinical and Experimental Rheumatology|April 1, 1983
The retention and distribution in the rabbit knee of a radionuclide complexed with a lipophilic chelator in liposomesD R Bard, C G Knight, D P Page Thomas
British Journal of Cancer|May 1, 1982
Toxicity of liposomal N-acyl daunorubicins to L929 cells in cultureD R Bard, C G Knight, D P Page-Thomas
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Biochemical and Biophysical Research Communications|November 9, 1970
Transient-state intermediates involved in the hydride transfer step of the glutamate dehydrogenase reactionH F Fisher, J R Bard, R A Prough
Annals of the New York Academy of Sciences|May 31, 1993
BisMSH-DTPA. A potential imaging agent for malignant melanomaD R Bard, E P Wraight, C G Knight
The American Surgeon|October 23, 2019
Traumatic PneumatoceleJacob D Edwards, Carlos J Anciano, Michael R Bard
Current Surgery|December 14, 2004
Laparoscopy in traumaClaudia E Goettler, Michael R Bard, Eric A Toschlog
New York State Journal of Medicine|September 1, 1976
Takayasu's arteritis. A worldwide entityA Lande, R Bard, P Rossi, et al.
Clinical and Experimental Rheumatology|July 1, 1985
Effect of the intra-articular injection of lutetium-177 in chelator liposomes on the progress of an experimental arthritis in rabbitsD R Bard, C G Knight, D P Page-Thomas
Biochemical Society Transactions|October 1, 1990
Targeting of a chelating derivative of a short-chain analogue of alpha-melanocyte stimulating hormone to Cloudman S91 melanomasD R Bard, C G Knight, D P Page-Thomas
British Journal of Cancer|December 1, 1990
A chelating derivative of alpha-melanocyte stimulating hormone as a potential imaging agent for malignant melanomaD R Bard, C G Knight, D P Page-Thomas
Clinical and Experimental Rheumatology|April 1, 1983
The retention and distribution in the rabbit knee of a radionuclide complexed with a lipophilic chelator in liposomesD R Bard, C G Knight, D P Page Thomas
British Journal of Cancer|May 1, 1982
Toxicity of liposomal N-acyl daunorubicins to L929 cells in cultureD R Bard, C G Knight, D P Page-Thomas
Pageof 13